SHR0302 and Steroid As First Line Therapy for Chronic GVHD

NCT04146207 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Chronic GVHD

Interventions

DRUG: SHR0302
DRUG: Prednisone

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine